Depression is treatable, and most people improve with some combination of therapy, medication, or lifestyle changes. About 60 to 70% of people respond to their first antidepressant, and talk therapy works equally well for many. The challenge is that full remission, where symptoms go away entirely, only happens for about a third of people on the first try. That means treatment often involves some trial and adjustment before you find what works.
Talk Therapy as a Starting Point
Psychotherapy is one of the two frontline treatments for depression, and for mild to moderate cases it can work on its own. The two most studied approaches are cognitive behavioral therapy (CBT) and interpersonal therapy (IPT). CBT helps you identify and reshape negative thought patterns that feed depression. IPT focuses on improving relationships and communication skills, since isolation and conflict often make depression worse.
Both therapies perform similarly overall, with large effect sizes in clinical trials. One notable difference: when therapy is used without medication, CBT tends to outperform IPT. When combined with an antidepressant, the two are essentially equal. This is worth knowing if you’re hoping to try therapy alone first. Either way, most structured therapy programs run 12 to 20 sessions, typically weekly.
How Antidepressants Work
Antidepressants work by adjusting the balance of chemical messengers in the brain, particularly serotonin, which helps regulate mood, emotions, and sleep. The most commonly prescribed class is SSRIs, which include medications like fluoxetine (Prozac), sertraline (Zoloft), and escitalopram (Lexapro). Doctors tend to start here because SSRIs have the fewest side effects relative to older antidepressants.
If SSRIs don’t work or cause problems, a second class called SNRIs targets both serotonin and norepinephrine, another brain chemical involved in energy and alertness. Beyond those, there are atypical antidepressants like bupropion, which affects dopamine and norepinephrine instead and is less likely to cause sexual side effects or weight gain.
One thing that catches people off guard is the timeline. It takes four to eight weeks for an antidepressant to fully work. You may notice changes in sleep, appetite, or energy before your mood actually lifts, which can feel discouraging. Sticking with it through that window matters, because many people quit too early thinking the medication failed.
Side Effects to Expect
SSRIs are considered safe, but they’re not side-effect-free. In real-world studies, the most commonly reported problems are sexual dysfunction (reported by roughly 56% of patients in one large cross-sectional survey), drowsiness (53%), and weight gain (49%). Less common but still notable: dry mouth (19%), insomnia (about 17%), fatigue (14%), and nausea (14%).
These numbers sound high, but severity varies enormously. Many side effects are mild and fade within the first few weeks. Others persist and become the reason people switch medications. If a side effect is bothering you, switching to a different antidepressant within the same class, or to a different class entirely, often solves the problem. This is one of the main reasons treatment involves some back and forth with your prescriber.
Exercise as Treatment
Physical activity is one of the most consistently supported non-drug treatments for depression, and a 2024 systematic review in the BMJ confirmed a clear dose-response relationship: the harder you exercise, the greater the benefit. Vigorous activity like running or interval training produced the strongest effects, but even light activity like walking or gentle yoga had clinically meaningful results.
Interestingly, the total weekly volume of exercise didn’t seem to matter as much as intensity. A shorter, harder workout may do more for your mood than a longer, easier one. The review also found that exercise helped regardless of whether someone had other health conditions or how severe their depression was at the start. This makes it a useful add-on at any stage of treatment, not just for mild cases.
When Standard Treatments Don’t Work
If you’ve tried two or more antidepressants without adequate improvement, you may have what’s called treatment-resistant depression. This affects a significant portion of people, since only about 30 to 40% achieve full remission on a first medication. At this point, options expand into brain stimulation therapies and newer drug approaches.
Transcranial magnetic stimulation (TMS) uses magnetic pulses to stimulate specific brain areas. It’s noninvasive, doesn’t require anesthesia, and is done in an outpatient setting. Response rates run around 49%, with about 32% achieving remission. It’s well tolerated, with low dropout rates and no significant cognitive side effects.
Electroconvulsive therapy (ECT) remains the most effective short-term treatment for severe or treatment-resistant depression, with a 53% remission rate and 64% response rate. It does require general anesthesia and can cause mild memory issues, which limits its appeal for some people. But for severe depression, especially cases involving psychosis or suicidal crisis, it works faster and more reliably than other options.
A newer option is esketamine, a nasal spray derived from ketamine that’s FDA-approved for treatment-resistant depression. It’s administered in a clinical setting under observation, initially twice weekly, then tapering to once weekly or less. It’s reserved for people who haven’t responded to multiple prior treatments, and it requires enrollment in a specific safety monitoring program. The treatment works through a different brain pathway than traditional antidepressants, which is why it can help when other medications haven’t.
Combining Approaches
The evidence consistently shows that combining therapy with medication works better than either alone, particularly for moderate to severe depression. Therapy gives you tools to manage negative thinking patterns and rebuild daily functioning. Medication addresses the biological underpinnings. Exercise adds a third layer that improves sleep, energy, and stress resilience.
Treatment rarely follows a straight line. The first approach may partially work, leading to an adjustment in dose, a switch in medication, or the addition of therapy. That iterative process is normal, not a sign of failure. Most people who stick with treatment, including trying alternatives when the first option falls short, eventually find a combination that brings meaningful relief.